glp-1 degradation metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion | Diabetologia Recent updates on GLP-1 agonists:

Patients in the UK seeking weight management support should consult their GP or an NHS specialist obesity service, where NICE-recommended options such as semaglutide (Wegovy) and tirzepatide (Zepbound) are currently available

[DOI] [PubMed] [Google Scholar] 63.Selley E, et al

The American Society of Anesthesiologists recommends discussing GLP-1 cessation with your surgeon because these medications slow gastric emptyingthe rate at which food leaves your stomachwhich can complicate anesthesia and aspiration risk during general anesthesia

It adds that bupropion can raise blood pressure and may increase suicidal ideation risk in some groups, particularly adolescents and young adults

For targeted gut health support, dedicated compounds covered in our peptides for gut health guide may be more appropriate than relying on retatrutide alone

Continuing Therapy & Maintenance Phase Once the desired weight loss is achieved, the dosage may be further adjusted to maintain results